semaglutide brand We have Semaglutide in stock

DXA data from the STEP-1 and SURMOUNT-1 trials show meaningful lean mass reduction during GLP-1-driven weight loss: approximately 9.7% of total lean tissue with semaglutide in STEP-1, and 10.9% with tirzepatide in SURMOUNT-1

Neither genetics nor compounded medications replace clinical evaluation

Ansari HUH, Qazi SU, Sajid F, et al

For example, a patient who has an allergy to a certain dye may need medication to be made without it, or an elderly patient or a child who cannot swallow a tablet or capsule may need medicine in liquid dosage form

The active ingredient has partially or fully broken down

A slower metabolism can lead to a plateau in weight loss because your body is using fewer calories to maintain its new body mass